Log In
Print this Print this

AuriCin (CYT-31000)

  Manage Alerts
Collapse Summary General Information
Company CytImmune Sciences Inc.
DescriptionColloidal gold bound tumor necrosis factor (TNF) with doxorubicin
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentDiscovery
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today